Financials
- Market Capitalization 2.06 B
- Employee 562
- Founded 2012
- CEO Carl Hansen
- Website www.abcellera.com
- Headquarter British Columbia, Canada
- FIGI BBG00LLW2MF2
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-7.27
Fiyat/satışlar oranı
13.18
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1939 | OCUL Ocular Therapeutix, Inc. - Common Stock | 9.70 USD | -1.82% | -5.09% | +7.90% | -15.65% | 2.12 B USD | ||
| 1958 | ATAI AtaiBeckley Inc. - Common Stock | 5.67 USD | +14.08% | +10.96% | +47.66% | +43.54% | 2.09 B USD | ||
| 1969 | ADMA ADMA Biologics Inc - Common Stock | 8.87 USD | -1.11% | -1.55% | +4.97% | -50.72% | 2.06 B USD | ||
| 1970 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.98 USD | -0.31% | -0.62% | -0.62% | +33.95% | 2.06 B USD |